A novel STING agonist for cancer immunotherapy and a SARS-CoV-2 vaccine adjuvant
Jun Wu, Lang Zhao, Bei-Bei Han, Hong-Guo Hu, Bo-Dou Zhang, Wen-Hao Li, Yong‐Xiang Chen, Yanmei Li
Abstract
for cancer immunotherapy and the adjuvant potential of the STING agonist in the SARS-CoV-2 vaccine for the first time.
Topics & Concepts
StingAdjuvantAgonistImmunotherapyMedicineCancer immunotherapySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)CancerCancer vaccineCoronavirus disease 2019 (COVID-19)VirologyImmunologyInternal medicineReceptorInfectious disease (medical specialty)DiseaseEngineeringAerospace engineeringinterferon and immune responsesViral Infections and Outbreaks ResearchViral Infections and Vectors